Broncus Holding Corp. (HK:2216) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Broncus Holding Corp. reports a significant 46% reduction in net loss for the first half of 2024 compared to the previous year, due to cost optimizations in production and R&D. The company is making strides in the Chinese market with its lung disease surgery consumables, as its products gain traction in hospitals across the country. Notably, the InterVapor Thermal Vapor Treatment System is widely recognized for its effectiveness and is now commercially used in over 60 hospitals in China.
For further insights into HK:2216 stock, check out TipRanks’ Stock Analysis page.